PET ligand for brain O-GlcNAc hydrolase
stably visualized in human HV
discovery strategy undisclosed
Sci. Transl. Med., May 13, 2020
National Institutes of Health / Eli Lilly
[18F]LSN3316612
![structure of [18F]LSN3316612](https://drughunter.com/wp-content/uploads/2021/09/DHMOTM2020-05-07-18FLSN3316612.png)
1 min read
[18F]LSN3316612 is a PET radiotracer for quantifying levels of O-GlcNAc hydrolase (OGA) in the brain. OGA is an enzyme involved in the post-translational modification of tau protein, and OGA may be a useful biomarker for neurodegenerative disease drug development. The fluorine radiolabel was introduced through nucleophilic aromatic substitution onto a nitropyridine.
Search By Structure
- eFT226 (zotatifin)
- JNJ-54717793
- DS-1971a
- BMS-986235/LAR-1219
- “Compound 34”
- GNE-149
- [18F]LSN3316612
- RO7185876
- ONO-8430506
- “Compound 15”
- NLG802
- “Compound 6g”
- GSK232
- LEI401
Molecules of the Month
2023
2022
2021
2020